Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

Share Price is delayed by 15 minutes
Get Live Data
362.50    3.50 (0.97%)
Bid:
362.50
Ask:
363.50
Spread: 1.00 (0.276%)
Market Cap: £1.20b
IHP Live PriceLast checked at - London Stock Exchange

Intraday IntegraFin Holdings Share Chart

Q4 Trading Update

14 Oct 2025 07:00

RNS Number : 1689D
IntegraFin Holdings plc
14 October 2025
 

 

LEI Number: 213800CYIZKXK9PQYE87

 

14 October 2025

 

IntegraFin Holdings plc

 

Q4 Trading Update

 

Strong Q4 net inflows consolidates excellent flows performance throughout FY25

 

IntegraFin Holdings plc ("IHP" or the "Group"), operator of Transact, the UK's premium investment platform for clients and UK financial advisers, is pleased to update on performance for the three months ended 30 September 2025.

 

Group highlights

 

· Strong Q4 FY25 net inflows to the Transact platform of £1.0bn (Q4 FY24: £0.8bn).

 

· Record quarter end funds under direction (FUD) on the Transact platform of £74.2bn, up 16% over the past year (FY24: £64.1bn).

 

· Average daily FUD on the platform of £71.9bn in Q4 FY25 (Q4 FY24: £63.0bn).

 

· Total FY25 Group revenue expected to be up 8% at c.£156.8m (FY24: £144.9m).

 

· Very strong total net inflows of £4.4bn in FY25, up 76% on the prior year (FY24: £2.5bn), representing 6.8% of opening FUD.

 

Outlook and guidance

· Transact is extremely well positioned to continue to attract and grow a strong share of adviser platform market net inflows in FY26 and beyond.

 

· We reiterate the revenue margin guidance that we announced in July:

In FY26 we expect the reduction in platform revenue margin to slow, with any decrease driven by the impact of positive market movements as client FUD moves into lower charging bands.

 

· The Group-wide cost review announced in July is progressing well. A further update on the business efficiencies and productivity opportunities identified will be provided at the FY25 results in December.

 

· We also reiterate the previous updated cost guidance that we announced in July:

FY25 remains unchanged at c.9% cost growth for total underlying administrative expenses.

FY26 and FY27 total underlying administrative expenses cost growth expected to slow to low single digit percentage as a result of our rigorous cost initiatives and operational leverage.

 

· A combination of the revenue growth fundamentals and the implementation of the cost review puts the Group in a strong position to accelerate profit growth in the coming years.

 

 

Alex Scott, IHP Group Chief Executive Officer, commented:

 

"IHP had a strong final quarter, continuing excellent net flow momentum for the Transact platform over the year. Net inflows in Q4 FY25 were up 28% year on year, bringing total FY25 net inflows to £4.4bn - an impressive 76% increase on FY24.

 

Q4 FY25 marked another consecutive quarter of gross inflows over £2bn, delivering our highest ever gross inflows in a financial year. The sustained strength of our gross inflows has been the main driver of our excellent net inflows momentum throughout the year, whilst outflows have remained stable. This has been driven by the enhancements we have made to our proprietary technology, particularly through the development of new APIs for the Transact platform. These ongoing enhancements will continue to broaden the appeal of the Transact platform to clients and advisers.

 

The Group-wide cost review is ongoing, and we have identified efficiency and productivity improvements which, when implemented, will deliver future cost savings and accelerate future earnings growth. We look forward to providing more information on the outcome of the cost review at the FY25 results in December 2025.

 

We continue to make financial planning easier by developing our proprietary technology adviser platform and enabling a more integrated ecosystem for clients and advice firms. This puts us in a strong position to deliver growing operating returns and to take advantage of the compelling opportunities present in the UK advice market."

 

Notice of full year results

 

The Group will announce its results for the year ended 30 September 2025 on 17 December 2025.

 

 

Transact platform reporting for Q4 FY25:

 

 

 

 

£m

Quarter ended 30 September 2025

Quarter ended 30 September 2024

Financial year ended 30 September 2025

Financial year ended 30 September 2024

Opening FUD

69,537

62,420

64,065

54,959

Inflows

2,510

2,162

10,102

8,104

Outflows

-1,498

-1,370

-5,750

-5,595

Net flows

1,012

792

4,352

2,509

Market movements

3,639

838

5,726

6,565

Other movements(1)

-15

15

30

32

Closing FUD

74,173

64,065

74,173

64,065

Average daily FUD for the period (£m)

71,942

63,044

67,856

59,628

Number of platform clients

246,191

234,998

246,191

234,998

 

Notes:(1)Includes fees, taxes and investment income

 

 

 

 

Transact platform historical information:

£m

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Opening FUD

54,959

58,010

61,020

62,420

64,065

65,880

65,896

69,537

Inflows

1,657

2,268

2,017

2,162

2,418

2,692

2,482

2,510

Outflows

-1,389

-1,478

-1,358

-1,370

-1,498

-1,483

-1,271

-1,498

Net flows

268

790

659

792

920

1,209

1,211

1,012

Market movements

2,786

2,196

745

838

880

-1,213

2,420

3,639

Other movements(1)

-3

24

-4

15

15

20

10

-15

Closing FUD

58,010

61,020

62,420

64,065

65,880

65,896

69,537

74,173

Average daily FUD for the period (£m)

55,474

58,567

61,435

63,044

65,462

67,148

66,847

71,942

Number of platform clients(2)

231,413

231,581

234,084

234,998

237,978

241,197

244,734

246,191

 

Notes:

(1) Includes fees, taxes and investment income.

(2) During Q4 FY25, our recurring account closure exercise for clients with small residual balances led to a reduction of c.1.3k clients and a reduction in FUD of less than £12k, helping improve operational efficiency.

 

 

 

Enquiries:

 

Investors

 

Luke Carrivick, Investor Relations Director

+44 020 7608 5463

Media

IHP@fgsglobal.com

FGS Global: Mike Turner

+44 7775992415

FGS Global: Chris Sibbald

+44 7855955531

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDGXUBDGUX
Date   Source Headline
9th Mar 20217:00 amRNSResult of AGM
23rd Feb 20212:21 pmRNSDirector/PDMR Shareholding
18th Feb 20214:19 pmRNSHolding(s) in Company
10th Feb 20214:30 pmRNSHolding(s) in Company
4th Feb 20212:28 pmRNSDirector/PDMR Shareholding
27th Jan 20211:51 pmRNSDirector/PDMR Shareholding
22nd Jan 20213:28 pmRNSDirector/PDMR Shareholding
20th Jan 20212:00 pmRNSNotice of AGM
19th Jan 20217:00 amRNS1st Quarter Results
15th Jan 20211:47 pmRNSDirector/PDMR Shareholding
13th Jan 20214:08 pmRNSHolding(s) in Company
11th Jan 20212:34 pmRNSHolding(s) in Company
11th Jan 202111:30 amRNSAcquisition
5th Jan 20216:28 pmRNSListing Rule 9.6.14(R) Disclosure
4th Jan 20214:45 pmRNSNo intention to make an offer for Nucleus
23rd Dec 20201:42 pmRNSDirector/PDMR Shareholding
17th Dec 202010:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSFinal Results
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
25th Nov 20207:00 amRNSAppointment of Joint Corporate Broker
24th Nov 20204:48 pmRNSDirector/PDMR Shareholding
5th Nov 202011:37 amRNSHolding(s) in Company
23rd Oct 20203:29 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSQ4 Funds Under Direction Update
30th Sep 202011:04 amRNSResult of General Meeting
28th Sep 20204:21 pmRNSHolding(s) in Company
25th Sep 202010:52 amRNSHolding(s) in Company
23rd Sep 20204:54 pmRNSHolding(s) in Company
23rd Sep 20204:22 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
15th Sep 20203:35 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSNotice of GM
7th Sep 202012:30 pmRNSDirector/PDMR Shareholding
1st Sep 20201:00 pmRNSDirectorate Change
24th Aug 20203:13 pmRNSDirector/PDMR Shareholding
5th Aug 20204:54 pmRNSDirector/PDMR Shareholding
4th Aug 20201:43 pmRNSHolding(s) in Company
3rd Aug 20209:45 amRNSHolding(s) in Company
27th Jul 202011:40 amRNSDirector/PDMR Shareholding
24th Jul 20203:16 pmRNSHolding(s) in Company
22nd Jul 20202:01 pmRNSDirector/PDMR Shareholding
22nd Jul 202012:00 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSQ3 Funds Under Direction Update
14th Jul 20202:30 pmRNSHolding(s) in Company
29th Jun 20203:10 pmRNSDirector/PDMR Shareholding
25th Jun 202010:27 amRNSDirector/PDMR Shareholding
24th Jun 202010:21 amRNSDirector/PDMR Shareholding
1st Jun 20201:35 pmRNSDirector/PDMR Shareholding
22nd May 20204:11 pmRNSHolding(s) in Company
22nd May 20202:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.